Seeking Alpha


Send Message
View as an RSS Feed
View cgm's Comments BY TICKER:

Latest  |  Highest rated
  • More on American Capital (ACAS) Q4 earnings: Net asset value of $17.84 up 29% Y/Y, and remains a large premium (33.9%) to the share price. 8.8M shares (almost 3% of the float) repurchased during quarter at average price of $11.72 - added $0.18 to NAV. (PR[View news story]
    I bought a bunch at 99 cents in 2009. I'm very happy with those. I wish I'd bought more. Still seems like a bargain. A healthy, growing company, with smart management, still buying up shares at well below NAV every quarter, and still growing nicely. When the NOLs are used up and the shares reach NAV, look for nice dividends to follow. This should make for a nice retirement asset.
    Feb 11, 2013. 02:10 PM | Likes Like |Link to Comment
  • Accuray Buys Some Breathing Room, But Orders Need To Materialize [View article]
    Lots of "if"s here.
    Feb 11, 2013. 10:36 AM | Likes Like |Link to Comment
  • Between ExOne's (XONE) stellar IPO and the 2012 gains seen by 3D Systems (DDD) and Stratasys (SSYS), it's clear investors are expecting big things from 3D printers. But low R&D spending could stall the industry's progress, warns Ashlee Vance. Unlike chips or hard drives, there's no guarantee of steady technology advances for printer nozzles and plastic melting. DDD and SSYS respectively spent just 6% and 9% of their 2011 revenue on R&D; Vance is more positive on upstarts such as Shapeways, who are finding ways to significantly cut production and materials costs. [View news story]
    I find the technology fascinating, but the stocks ae very overpriced. I feel that it is very likely there will be a shakeout, but it's not clear from what level or when.
    Feb 9, 2013. 10:08 PM | Likes Like |Link to Comment
  • Berkshire Hathaway (BRK.B) is set to raise capital, filing a shelf offering to issue an as-of-yet undisclosed amount of senior unsecured debt. The company plans to undertake the issuance on February 1. The plans for the proceeds are up for speculation. [View news story]
    I doubt Buffett would sell any shares. His favorite holding period is "forever". He would rather hold onto his shares and have his heirs take their shares with a stepped-up basis so there is not capital gains tax. It looks like they want to take advantage of low rates now so they are ready to pounce on a large acquisition if the opportunity presents itself.
    Jan 29, 2013. 11:40 AM | Likes Like |Link to Comment
  • Cheap natural gas and increasingly competitive labor costs are bringing factories and jobs back to the U.S., Barron's says in identifying eight stocks it believes should prosper - particularly chemical producers and steelmakers - in a gas-fueled manufacturing upswing: SWN, LYB, NUE, DOV, CPN, CF, WMB, UNP[View news story]
    LNG does better with cheap NG. It will benefit from export of NG. the lower the price, the more export demand.
    Jan 28, 2013. 11:55 PM | Likes Like |Link to Comment
  • American Capital: Back In The Business-Building Business [View article]
    You wrote a good article and I agree with your conclusions. My onluy quibble is with your claim that ACAS threatened bankruptcy to secure new terms. They consistently stated that they would not file bankruptcy and their loan terms allowed them to continue, despite shrinking values for their assets so long as they continued to pay the loan payments, without their lenders having the ability to push them into bankruptcy.
    Jan 11, 2013. 05:56 PM | 2 Likes Like |Link to Comment
  • The All-Aristocrat Team: 20 Dividend Stocks Retirees Should Own In 2013 (Part 4) [View article]
    It's easy to raise dividends every year when you start out with a negligible dividend. These stocks all pay practically nothing in yield. I'd rather look at stocks that pay at least 5% and contantly raise dividends, such as various MLPs (which also have tax advantages).
    Jan 11, 2013. 11:13 AM | 3 Likes Like |Link to Comment
  • ViroPharma (VPHM +3.4%) trades higher after releasing its 2013 outlook this morning. The company says it expects net product sales to be between $450M to $475M. Analysts are looking for around $467M. The numbers are encouraging, because Cinryze has become key to the drug developer's future as the it's former blockbuster antibiotic Vancocin is expected to see sales hurt by the potential entry of generic rivals going forward. [View news story]
    The management here has played their drug development well. They have gone from a "one-trick pony" to a firm that brings additional income sources to market in thime to more than offset the effects of generic competition. The stock has acted well as a result. One very pleased stockholder here.
    Jan 7, 2013. 01:04 PM | Likes Like |Link to Comment
  • American Capital: The Buyback That Keeps Giving [View article]
    It's been grat ever since it bottomed during the Great Recession. I look forward to more gains as it climbs to approach its climbing NAV.
    Jan 6, 2013. 06:01 PM | 1 Like Like |Link to Comment
  • DryShips: Be Patient And Wait For The Turnaround [View article]
    DRYS sells for less than its ownership in ORIG.
    Jan 1, 2013. 06:05 PM | Likes Like |Link to Comment
  • Comparing Annaly Capital Management And American Capital Agency [View article]
    False. ACAS never filed for bankruptcy. They had a tough time for a while, as did most companies, particularly REITs, in the recession, but they have gone way up since. The formation of AGNC is a separate issue; and it has been a major success both in terms of generating income and captial gains. Jonk - If you want to maintain any credibility you should not make obviously false statements.
    Dec 27, 2012. 07:41 PM | 3 Likes Like |Link to Comment
  • Fiscal Cliff And Deficit Conversation Misses The Point [View article]
    You have it pegged. If only you could convince the folks in Washington to do something about it.
    Dec 6, 2012. 04:13 PM | 9 Likes Like |Link to Comment
  • Billionaire Leon Cooperman Likes These Dividend Stocks [View article]
    LINE is hedged out for years, so not commodity price risk for quite a while.
    Nov 20, 2012. 04:15 PM | 4 Likes Like |Link to Comment
  • The exponential growth and huge reserves of North Dakota's Bakken field puts it on course to produce more than 1M bbl/day by mid-2013, which would rank it among the world's most elite oil fields. Just 5K wells have been completed, but Continental (CLR) thinks the core could support up to 52K wells with four to eight wells per 1,280-acre unit for full development. [View news story]
    Oil sands are not very economical. If the oil price declines much more, it may not be even worth mining. The costs are high and the environmental issues are significant. I'd rather be in the Bakken.
    Nov 13, 2012. 01:48 PM | Likes Like |Link to Comment
  • Profit From Obamacare With Amerigroup [View article]
    How about doing a little research before you make a recommendation. AGP is being bouth out by WLP, which is largley why it was up so much, and also why it is no longer a stock to buy.
    Nov 7, 2012. 11:54 AM | Likes Like |Link to Comment